Re-engineering laboratory diagnostics for preventing preanalytical errors

Clinical Biochemistry

Volumn 49, Issue 18, 2016, Pages 1313-1314

  Lippi, Giuseppe ^a   Bowen, Raffick ^b   Adcock, Dorothy M ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Esoterix Inc   (United States)

Author keywords

Errors; Laboratory diagnostics; Laboratory medicine; Preanalytical variability

Indexed keywords

ANALYTICAL ERROR; BLOOD COLLECTION TUBE; CLINICAL LABORATORY; DIAGNOSTIC ERROR; EDITORIAL; ENGINEERING; HUMAN; LABORATORY DIAGNOSIS; MEDICAL ERROR; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION PROCESS; DEVICES; LABORATORY TECHNIQUE; PATIENT SAFETY; SPECIMEN HANDLING;

CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC ERRORS; HUMANS; PATIENT SAFETY; SPECIMEN HANDLING;

EID: 84993958665     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.10.010     Document Type: Editorial

References (25)

1. [1] Leape, L.L., Error in medicine. JAMA 272 (1994), 1851–1857.
2. [2] Makary, M.A., Daniel, M., Medical error-the third leading cause of death in the US. BMJ, 353, 2016 May 3, i2139.
3. [3] Lippi, G., Plebani, M., Graber, M.L., Building a bridge to safe diagnosis in health care. The role of the clinical laboratory. Clin. Chem. Lab. Med. 54 (2016), 1–3.
4. [4] National Academies of Sciences, Engineering, and Medicine, Improving Diagnosis in Health Care. 2015, The National Academies Press, Washington, DC.
5. [5] Plebani, M., Lippi, G., To err is human. To misdiagnose might be deadly. Clin. Biochem. 43 (2010), 1–3.
6. [6] Lippi, G., Wisdom of theragnostics, other changes. MLO Med. Lab. Obs., 40, 2008, 6.
7. [7] Adcock, D.M., Favaloro, E.J., Lippi, G., Critical pre-examination variables in the hemostasis laboratory and their quality indicators. Clin. Biochem. 49 (2016), 1315–1320.
8. [8] Bowen, R.A.R., Adcock, D., Blood collection tubes as medical devices: the potential to affect assays and proposed verification and validation processes for the clinical laboratory. Clin Biochem. 49 (2016), 1321–1330.
9. [9] Lombardi, G., Perego, S., Sansoni, V., Banfi, G., Circulating miRNA as fine regulators of the physiological responses to physical activity: pre-analytical warnings for a novel class of biomarkers. Clin. Biochem. 49 (2016), 1331–1339.
10. [10] Cornes, M.P., Exogenous sample contamination. Sources and interference. Clin. Biochem. 49 (2016), 1340–1345.
11. [11] Delanghe, J., Preanalytics in urinalysis. Clin. Biochem. 49 (2016), 1346–1350.
12. [12] Devgun, M.S., Richardson, C., Direct bilirubin in clinical practice — interpretation and haemolysis interference guidance reassessed. Clin. Biochem. 49 (2016), 1351–1353.
13. [13] Kang, Q., Henry, N.L., Paoletti, C., Jiang, H., Vats, P., Chinnaiyan, A.M., Hayes, D.F., Merajver, S.D., Rae, J.M., Tewari, M., Comparative analysis of circulating tumor DNA stability in K3EDTA, Streck, and CellSave blood collection tubes. Clin. Biochem. 49 (2016), 1354–1360.
14. [14] Mansoor, M.A., Andersen, D.O., In vivo effect of N-ethylmaleimide (NEM) on the measurement of nitrate in plasma. Clin. Biochem. 49 (2016), 1361–1363.
15. [15] Lima-Oliveira, G., Guidi, G.C., Salvagno, G.L., Brocco, G., Danese, E., Lippi, G., Estimation of the imprecision on clinical chemistry testing due to fist clenching and maintenance during venipuncture. Clin. Biochem. 49 (2016), 1364–1367.
16. [16] Osinga, T.E., Kema, I.P., Kerstens, M.N., de Jong, W.H., van Faassen, M., Dullaart, R.P., Links, T.P., van der Horst-Schrivers, A.N., No influence of antihypertensive agents on plasma free metanephrines. Clin. Biochem. 49 (2016), 1368–1371.
17. [17] Xia, T., Gao, S., Shu, C., Wen, Y., Yun, Y., Tao, X., Chen, W., Zhang, F., Analysis of amino acids in human blood using UHPLC-MS/MS: potential interferences of storage time and vacutainer tube in pre-analytical procedure. Clin. Biochem. 49 (2016), 1372–1378.
18. [18] Wong, F.C., Sun, K., Jiang, P., Cheng, Y.K., Chan, K.C., Leung, T.Y., Chiu, R.W., Lo, Y.M., Cell-free DNA in maternal plasma and serum: a comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. Clin. Biochem. 49 (2016), 1379–1386.
19. [19] Rodríguez-Capote, K., Schnabl, K.L., Maries, O.R., Janzen, P., Higgins, T.N., Stability of specific IgE antibodies to common food and inhalant allergens. Clin. Biochem. 49 (2016), 1387–1389.
20. [20] Depreter, B., Stove, V., Delanghe, J., Sampling on ice will not yield reliable uric acid monitoring in rasburicase-treated patients. Clin. Biochem. 49 (2016), 1390–1395.
21. [21] Parra-Robert, M., Rico-Santana, N., Alcaraz-Quiles, J., Sandalinas, S., Fernández, E., Falcón, I., Pérez-Riedweg, M., Bedini, J.L., Improvement in the stability of serum samples stored in an automated refrigerated module. Clin. Biochem. 49 (2016), 1396–1398.
22. [22] Lima-Oliveira, G., Adcock Funk, D.M., Salvagno, G.L., Favaloro, E.J., Lippi, G., Mixing of thawed coagulation samples prior to testing: is any technique better than another?. Clin. Biochem. 49 (2016), 1399–1401.
23. [23] Juricic, G., Saracevic, A., Kopcinovic, L.M., Bakliza, A., Simundic, A.M., The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive. Clin. Biochem. 49 (2016), 1402–1405.
24. [24] Carey, R., Lunt, H., Heenan, H.F., Frampton, C.M., Florkowski, C.M., Collection tubes containing citrate stabiliser over-estimate plasma glucose, when compared to other samples undergoing immediate plasma separation. Clin. Biochem. 49 (2016), 1406–1411.
25. [25] Roccaforte, V., Daves, M., Platzgummer, S., Lippi, G., The impact of different sample matrices in delayed measurement of glucose. Clin. Biochem. 49 (2016), 1412–1415.